Cellumed Statistics

Total Valuation

Cellumed has a market cap or net worth of KRW 51.54 billion. The enterprise value is 51.29 billion.

Market Cap	51.54B
Enterprise Value	51.29B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Cellumed has 54.95 million shares outstanding. The number of shares has increased by 14.33% in one year.

Current Share Class	54.95M
Shares Outstanding	54.95M
Shares Change (YoY)	+14.33%
Shares Change (QoQ)	+1.28%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	0.03%
Float	38.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.40
PB Ratio	5.69
P/TBV Ratio	5.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.63
EV / Sales	0.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.29

Financial Position

The company has a current ratio of 0.90, with a Debt / Equity ratio of 1.07.

Current Ratio	0.90
Quick Ratio	0.45
Debt / Equity	1.07
Debt / EBITDA	n/a
Debt / FCF	-4.41
Interest Coverage	-6.29

Financial Efficiency

Return on equity (ROE) is -198.37% and return on invested capital (ROIC) is -18.39%.

Return on Equity (ROE)	-198.37%
Return on Assets (ROA)	-7.74%
Return on Invested Capital (ROIC)	-18.39%
Return on Capital Employed (ROCE)	-71.66%
Revenue Per Employee	1.45B
Profits Per Employee	-354.44M
Employee Count	89
Asset Turnover	1.89
Inventory Turnover	16.15

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.28% in the last 52 weeks. The beta is 1.18, so Cellumed's price volatility has been higher than the market average.

Beta (5Y)	1.18
52-Week Price Change	-45.28%
50-Day Moving Average	1,168.36
200-Day Moving Average	2,038.01
Relative Strength Index (RSI)	28.21
Average Volume (20 Days)	190,308

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellumed had revenue of KRW 129.14 billion and -31.55 billion in losses. Loss per share was -648.25.

Revenue	129.14B
Gross Profit	9.43B
Operating Income	-8.46B
Pretax Income	-32.08B
Net Income	-31.55B
EBITDA	-7.28B
EBIT	-8.46B
Loss Per Share	-648.25

Full Income Statement

Balance Sheet

The company has 10.25 billion in cash and 9.71 billion in debt, giving a net cash position of 540.53 million or 9.84 per share.

Cash & Cash Equivalents	10.25B
Total Debt	9.71B
Net Cash	540.53M
Net Cash Per Share	9.84
Equity (Book Value)	9.06B
Book Value Per Share	170.40
Working Capital	-6.13B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -418.53 million and capital expenditures -1.78 billion, giving a free cash flow of -2.20 billion.

Operating Cash Flow	-418.53M
Capital Expenditures	-1.78B
Free Cash Flow	-2.20B
FCF Per Share	-40.08

Full Cash Flow Statement

Margins

Gross margin is 7.30%, with operating and profit margins of -6.55% and -24.43%.

Gross Margin	7.30%
Operating Margin	-6.55%
Pretax Margin	-24.84%
Profit Margin	-24.43%
EBITDA Margin	-5.64%
EBIT Margin	-6.55%
FCF Margin	n/a

Dividends & Yields

Cellumed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.33%
Shareholder Yield	-14.33%
Earnings Yield	-61.20%
FCF Yield	-4.27%

Stock Splits

The last stock split was on April 28, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 28, 2017
Split Type	Reverse
Split Ratio	0.1

Scores

Cellumed has an Altman Z-Score of -0.5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.5
Piotroski F-Score	n/a